In contrast, the dissociative steroid vamorolone shares the GR with prednisone as its drug target, and both show significant improvements of DMD in patients (Hoffman et al., 2019; Mah et al., 2022; Smith et al., 2020). Here, NR3C1 is linked to Duchenne muscular dystrophy.